Evidence map›Paper›PMID 21593863›Full record

ReviewNature2011

Lessons on the pathogenesis of aneurysm from heritable conditions.

Mark E Lindsay, Harry C Dietz

Open access · greenAbstract readReview
In one paragraph

Review in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 223 papers.

0numbers the graph read from it
0cells of the map it votes in
223citing papers in PubMed
31.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

223 citing papers in PubMed, 461 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Fibronectin-induced overactivation of αNature communications · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genotype/phenotype correlation in a patient with multiple abdominal and popliteal aneurysms.Journal of vascular surgery cases and innovative techniques · 2025
    Article
  16. Article
  17. Mitochondrial NADNature cardiovascular research · 2025
    Article
  18. Article
  19. Article
  20. Article

163 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mark E LindsayDivision of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-1832, USA.
Harry C Dietz
Howard Hughes Medical Institute · US

Funding

MOLECULAR BIOLOGY OF THE MARFAN SYNDROMER01AR041135 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI DIETZ, HARRY C., III · 1992 to 2016
$5.2M
Development Underpinnings of Acquired Aortic Aneurysm in Marfan SyndromeK08HL107738 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI LINDSAY, MARK E · 2011 to 2013
$403k
Howard Hughes Medical InstituteNHLBI NIH HHS K08 HL107738NIAMS NIH HHS R01 AR041135
6 · The paper itself

Abstract

Aortic aneurysm is common, accounting for 1-2% of all deaths in industrialized countries. Early theories of the causes of human aneurysm mostly focused on inherited or acquired defects in components of the extracellular matrix in the aorta. Although several mutations in the genes encoding extracellular matrix proteins have been recognized, more recent discoveries have shown important perturbations in cytokine signalling cascades and intracellular components of the smooth muscle contractile apparatus. The modelling of single-gene heritable aneurysm disorders in mice has shown unexpected involvement of the transforming growth factor-β cytokine pathway in aortic aneurysm, highlighting the potential for new therapeutic strategies.

Indexed as

Angiotensin IIAnimalsAortic AneurysmDisease Models, AnimalElastinHumansMuscle, Smooth, VascularTransforming Growth Factor betaAngiotensin IIElastinTransforming Growth Factor beta

Identifiers

PMID21593863
PMCPMC3622871
OpenAlexW2041938961

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.